STAT+: Investing in Pacific Biosciences, SoftBank pays a 540% premium to offer price for entire company

SoftBank, the Japanese tech conglomerate famous for paying questionable sums to invest in startups, has paid a hefty sum to invest in the genome sequencing company Pacific Biosciences.

It’s a $900 million investment in the form of convertible debt, meaning SoftBank can exchange the money for stock at a price of $43.50 per share.

Continue to STAT+ to read the full story…

Related Articles

Responses

Your email address will not be published. Required fields are marked *

Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about chronicles from TreatMyBrand directly in your inbox